Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer. [electronic resource]
- Seminars in oncology Oct 1999
- 32-40; discussion 41-2 p. digital
Publication Type: Journal Article; Review
0093-7754
Antineoplastic Agents, Phytogenic--therapeutic use Antineoplastic Combined Chemotherapy Protocols--therapeutic use Camptothecin--administration & dosage Carcinoma, Non-Small-Cell Lung--drug therapy Clinical Trials as Topic Docetaxel Humans Irinotecan Lung Neoplasms--drug therapy Paclitaxel--administration & dosage Taxoids